Enterprise Vaccinopole

Iran Foreign Investment Company (IFIC) owns 60% of Paris company Vaccinopole

Status:High Alert – Entity affiliated with Designated / Sanctioned / Illicit entities

Risk Level:89%

May harm your business future.

This entity is connected with designated / sanctioned entities who are helping Iranian Regime Terrorist Activities & development of WMD

The Vaccinopole entity manufactures basic pharmaceutical products. Its headquarters is located 46 rue Balard in the heart of the 15th arrondissement in the municipality of Paris. Its registration dates back to March of this year. The President is currently Raymond Abolhassani;

According to reports Iran Foreign Investment Company (IFIC) owns 60% of Paris company Vaccinopole SAS. – “IFIC in France, it bought the medicine factory in the winemaking region of Champagne through a Paris company Vaccinopole SAS, in which it owns a 60% stake, French corporate records show. The French-Iranian scientist, Raymond Abolhassan, owns the rest;

Iran Foreign Investment Company is used by the mullahs to invest money around the world and is investment arm of the “Oil stabilization Fund”. The U.S. Department of the Treasury identified Iran Foreign Investment Company (IFIC) to be owned or controlled by the Government of Iran. By identifying these entities – including banks, investment companies and technology firms – U.S. persons and others are better able to identify Iranian Government entities and protect themselves against the risks posed by such entities. IFIC is added to the Specially Designated Nationals (SDN) list maintained by the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC) on 11/05/2018;

Pharmaceutical industry

Also Known As:
Vaccinopole SAS



46 Rue Balard 75015 Paris

Person of interests:
Abolhassani Raymond – President
Vahid Sharif
Abolhassani Raymond
Farhad Zargari

Reason for the color:
» IFIC owns shares of Enterprise Vaccinopole;